Pharmaceutical giant Pfizer has received U.S. approval for a gene therapy against a form of hemophilia, a rare and inherited blood clotting disorder, the company said Friday. Beqvez, which is given as a single intravenous infusion, was shown in a clinical trial of 45 people to be better at (...)
Site référencé: Raw Story
Raw Story
Analysis ticks off nearly 30 ways Trump mirrors tyranny of 'Mad King' George III
3/07/2025
'History will remember' : Dems vow vengeance after GOP's 'ultimate betrayal'
3/07/2025
Public spat erupts as Chris Cuomo blames AOC for Dem losses in 2024
3/07/2025
‘You gotta fight’ : Dems declare midterms battle has begun
3/07/2025
Republicans just declared war on Grandma
3/07/2025
Trump's megabill finally passes after GOP turmoil
3/07/2025
